Genfit S.A.
$8.95+4.07%(+$0.35)
TickerSpark Score
72/100
40
Valuation
55
Profitability
100
Growth
64
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNFT research report →
52-Week Range86% of range
Low $2.55
Current $8.95
High $10.00
Companywww.genfit.com
Genfit S. A. , a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
- CEO
- M. Pascal Prigent
- IPO
- 2019
- Employees
- 180
- HQ
- Loos, FR
Price Chart
+72.05% · this period
Valuation
- Market Cap
- $445.68M
- P/E
- -4.97
- P/S
- 6.36
- P/B
- -18.07
- EV/EBITDA
- -79.07
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 26.02%
- Op Margin
- -84.25%
- Net Margin
- -127.40%
- ROE
- -596.44%
- ROIC
- -41.41%
Growth & Income
- Revenue
- $67.00M · 134.56%
- Net Income
- $1.51M · 105.22%
- EPS
- $0.03 · 105.17%
- Op Income
- $3.28M
- FCF YoY
- 124.55%
Performance & Tape
- 52W High
- $10.00
- 52W Low
- $2.55
- 50D MA
- $4.12
- 200D MA
- $3.94
- Beta
- 0.87
- Avg Volume
- 10.37K
Get TickerSpark's AI analysis on GNFT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GNFT Coverage
We haven't published any research on GNFT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GNFT Report →Similar Companies
NTHI-1.09%
Neonc Technologies Holdings, Inc.
$5.42
TARA+9.68%
Protara Therapeutics, Inc.
$4.76
PRLD+5.39%
Prelude Therapeutics Incorporated
$4.50
IVVD+4.81%
Invivyd, Inc.
$1.09
MDWD+1.23%
MediWound Ltd.
$16.89
SLS+18.18%
SELLAS Life Sciences Group, Inc.
$8.97
EPRX+1.27%
Eupraxia Pharmaceuticals Inc.
$6.37
IVA+4.68%
Inventiva S.A.
$5.14